Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 4/20 | 0.63 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.63 |
| ▸ | AKR1C1 | Q04828 | 4/20 | 0.63 |
| ▸ | AKR1C4 | P17516 | 3/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.57 |
| ▸ | TTR | P02766 | 1/20 | 0.52 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.52 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.42 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29593387 | 1.00 | AKR1C3 (0.63) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL30555489 | 0.86 | AKR1C3 (0.57) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL605556 | 0.86 | AKR1C3 (0.57) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL5356578 | 0.82 | PRNP (0.53) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL28361591 | 0.81 | AKR1C3 (0.52) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL18281055 | 0.81 | AKR1C4 (0.52) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL10964657 | 0.80 | ERN1 (0.43) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL29171688 | 0.78 | AKR1C4 (0.48) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL330545 | 0.77 | AKR1C3 (1.00) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 | |
| SCHEMBL29387062 | 0.77 | AKR1C3 (1.00) | AKR1C3AKR1C2AKR1C1AKR1C4PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113816940-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-21 | — | — | CN | claimed |
| CN-113754634-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-07 | — | — | CN | claimed |
| US-9604929-B2 | Functionalized carbon nanoparticles and functional polymer fibers prepared using the same | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2017-03-28 | — | — | US | claimed |
| US-20150204009-A1 | FUNCTIONALIZED CARBON NANOPARTICLES AND FUNCTIONAL POLYMER FIBERS PREPARED USING THE SAME | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-07-23 | — | — | US | claimed |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107973-A1 | AEROSOL-MODIFYING ADDITIVE COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107967-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260107969-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260060287-A1 | AEROSOLIZABLE COMPOSITION INCLUDING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | RAI STRATEGIC HOLDINGS INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260042744-A1 | NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES | REYNOLDS TOBACCO CO R (US) | 2026-02-12 | — | — | US | disclosed |
| CN-102981368-B | Antireflective film-forming composition containing vinyl ether compound | NISSAN CHEMICAL IND LTD | 2015-03-04 | — | — | CN | disclosed |
| US-8501393-B2 | Lithography; photoresists; semiconductors | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-08-06 | — | — | US | disclosed |
| EP-2592476-A1 | Antireflective coating forming composition containing vinyl ether compound and polyimide | Nissan Chemical Industries, Ltd. (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-20080138744-A1 | Anti-Reflective Coating Forming Composition Containing Vinyl Ether Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
| US-7309560-B2 | Composition for forming anti-reflective coating | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-18 | — | — | US | disclosed |
| EP-1757987-A1 | ANTIREFLECTIVE FILM-FORMING COMPOSITION CONTAINING VINYL ETHER COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
| US-20050118749-A1 | Composition for forming anti-reflective coating | NISSAN CHEMICAL INDUSTRIES (JP) | 2005-06-02 | — | — | US | disclosed |
| EP-1484645-A1 | COMPOSITION FOR FORMING ANTI-REFLECTION COATING | Nissan Chemical Industries, Ltd. (JP) | 2004-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107971-A1 | AEROSOL GENERATING MATERIAL IN DISCRETE PORTIONS COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHRM3, CHRM1 | AKR1C3 1891/4885AKR1C2 3007/4885AKR1C1 2737/4885 |
| US-20260107968-A1 | END PLUG COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE | ALK, EXOSC4, EXOSC9 | AKR1C3 1752/4885AKR1C2 3511/4885AKR1C1 3035/4885 |
| US-20260107967-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, EXOSC4, CHRM3 | AKR1C3 1183/4885AKR1C2 2773/4885AKR1C1 2486/4885 |
| US-20260107969-A1 | AEROSOL GENERATING MATERIAL COMPRISING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | CHRM1, CHRM3, ATRIP | AKR1C3 1678/4885AKR1C2 2197/4885AKR1C1 2159/4885 |
| US-20260042744-A1 | NICOTINE SALTS, CO-CRYSTALS, AND SALT CO-CRYSTAL COMPLEXES | SLC6A3, NAPRT, SLC6A4 | AKR1C3 2988/4885AKR1C2 2563/4885AKR1C1 2762/4885 |
| US-20260060287-A1 | AEROSOLIZABLE COMPOSITION INCLUDING A SUBSTITUTED 3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE COMPOUND | CHRM3, CHRM1, ADRA1D | AKR1C3 3009/4885AKR1C2 3530/4885AKR1C1 3326/4885 |
| US-20260107973-A1 | AEROSOL-MODIFYING ADDITIVE COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | CHRM3, CHRM1, CHRM2 | AKR1C3 1968/4885AKR1C2 3187/4885AKR1C1 3003/4885 |
| US-20260107972-A1 | AEROSOL GENERATING GEL MATERIAL COMPRISING A SUBSTITUTED 3-(1 METHYLPYRROLIDIN-2-YL)PYRIDINE | ACTN1, ARPC3, ARPC4 | AKR1C3 2546/4885AKR1C2 2984/4885AKR1C1 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.